These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 729477)

  • 1. [Human diploid cell (HDC) rabies vaccine immunoprophylaxis in persons at risk (author's transl)].
    Haase M; Schneider W
    Dtsch Med Wochenschr; 1978 Dec; 103(51):2033-6. PubMed ID: 729477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Investigation of antibody levels following rabies vaccination in the subjects who were biten by animals].
    Baysal B; Tosun S; Ozdemir M; Doğan M
    Mikrobiyol Bul; 2009 Jan; 43(1):127-31. PubMed ID: 19334389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intradermal pre-exposure rabies immunisation in New Zealand.
    Shaw MM; Leggat PA; Williams ML
    Travel Med Infect Dis; 2006 Jan; 4(1):29-33. PubMed ID: 16887722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human rabies immunoprophylaxis using HDC (MRC-5) vaccine.
    Cox JH; Klietmann W; Schneider LG
    Dev Biol Stand; 1978; 40():105-8. PubMed ID: 680382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Preventive rabies vaccination using vaccine prepared from human diploid cells].
    Costy-Berger F
    Dev Biol Stand; 1978; 40():101-4. PubMed ID: 680381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pre-exposure rabies vaccination using a new duck embryo vaccine].
    Bachmann G; Steffen R; Glück R; Wegmann A; Schär M
    Schweiz Med Wochenschr; 1985 Jun; 115(25):863-5. PubMed ID: 4023675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody response after a four-site intradermal booster vaccination with cell-culture rabies vaccine.
    Tantawichien T; Benjavongkulchai M; Limsuwan K; Khawplod P; Kaewchompoo W; Chomchey P; Sitprija V
    Clin Infect Dis; 1999 May; 28(5):1100-3. PubMed ID: 10452642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rabies antibody seroprotection rates among travelers in Nepal: "rabies seroprotection in travelers".
    Ranney M; Partridge R; Jay GD; Rozzoli DE; Pandey P
    J Travel Med; 2006; 13(6):329-33. PubMed ID: 17107424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody response after a two-year intradermal booster of rabies human diploid cell vaccine.
    Horman JT; Rullán JV; Myers RA; Bond JO; Israel E; Joseph JM
    J Am Vet Med Assoc; 1987 Jul; 191(2):185-7. PubMed ID: 3610792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ten year longitudinal study of efficacy and safety of purified chick embryo cell vaccine for pre- and post-exposure prophylaxis of rabies in Indian population.
    Sehgal S; Bhattacharya D; Bhardwaj M
    J Commun Dis; 1995 Mar; 27(1):36-43. PubMed ID: 7636151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunogenicity, efficacy and reactogenicity of a human diploid cell strain (HDCS) rabies vaccine in man; recommendations for pre- and post-exposure application (vaccination scheme) (author's transl)].
    Kuwert EK; Marcus I; Höher PG; Werner J; Iwand A; Helm EB
    Med Klin; 1977 May; 72(18):797-805. PubMed ID: 865381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced dose pre-exposure primary and booster intradermal rabies vaccination with a purified chick embryo cell vaccine (PCECV) is immunogenic and safe in adults.
    Roukens AH; Vossen AC; van Dissel JT; Visser LG
    Vaccine; 2008 Jun; 26(27-28):3438-42. PubMed ID: 18511158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunity to rabies after administration of prophylactic human diploid-cell vaccine.
    Oelofsen MJ; Gericke A; Janse van Rensburg MN; Smith MS
    S Afr Med J; 1991 Aug; 80(4):189-90. PubMed ID: 1876954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity of two modern tissue culture rabies vaccines in pre-exposure prophylaxis.
    Kulkarni PS; Raut SK; Jadhav SS; Kapre SV; Deuskar N
    Hum Vaccin; 2007; 3(5):183-6. PubMed ID: 17637572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of antibody responses after vaccination with two inactivated rabies vaccines.
    Minke JM; Bouvet J; Cliquet F; Wasniewski M; Guiot AL; Lemaitre L; Cariou C; Cozette V; Vergne L; Guigal PM
    Vet Microbiol; 2009 Jan; 133(3):283-6. PubMed ID: 18757142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-exposure use of human diploid cell culture rabies vaccine.
    Kuwert EK; Marcus I; Werner J; Scheiermann N; Höher PG; Thraenhart O; Hierholzer E; Wiktor TJ; Koprowski H
    Dev Biol Stand; 1976 Dec 13-15; 37():273-86. PubMed ID: 1031689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rabies antibody titers in vaccinees: protection, failure and prospects.
    Dutta JK; Pradhan SC; Dutta TK
    Int J Clin Pharmacol Ther Toxicol; 1992 Mar; 30(3):107-12. PubMed ID: 1506120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Booster effect of human diploid cell antirabies vaccine in previously treated persons.
    Fayaz A; Simani S; Nour-Salehi S; Bahmanyar M
    JAMA; 1981 Nov; 246(20):2334-5. PubMed ID: 7299954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experience with new vaccines in rabies vaccination treatment (author's transl)].
    Helm EB; Dillmann W; Stille W
    MMW Munch Med Wochenschr; 1978 Mar; 120(9):293-6. PubMed ID: 306059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Boosting effect of purified chick embryo cell rabies vaccine using the intradermal route in persons previously immunized by the intramuscular route or vice versa.
    Sudarshan MK; Madhusudana SN; Mahendra BJ; Narayana DH; Giri MS; Muhamuda K; Ravish HS; Venkatesh GM
    Natl Med J India; 2006; 19(4):192-4. PubMed ID: 17100105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.